A phase II study of durvalumab, doxorubicin, and ifosfamide in recurrent and/or metastatic pulmonary sarcomatoid carcinoma (KCSG LU-19-24).

Keam, Bhumsuk; Youk, Jeonghwan; Kim, Tae Min; Lee, Gyeong-Won; Kim, Dong-Wan; Kim, Miso

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

A phase II study of durvalumab, doxorubicin, and ifosfamide in recurrent and/or metastatic pulmonary sarcomatoid carcinoma (KCSG LU-19-24).

Authors: Keam, Bhumsuk; Youk, Jeonghwan; Kim, Tae Min; Lee, Gyeong-Won; Kim, Dong-Wan; Kim, Miso

Issue Date: Jun-2025

Publisher: American Society of Clinical Oncology

Citation: Journal of Clinical Oncology, v.43, no.16_SUPPL

Indexed: SCIE
SCOPUS

Journal Title: Journal of Clinical Oncology

Volume: 43

Number: 16_SUPPL

URI: https://scholarworks.gnu.ac.kr/handle/sw.gnu/82595

DOI: 10.1200/JCO.2025.43.16_suppl.8566

ISSN: 0732-183X
1527-7755

Files in This Item: There are no files associated with this item.

Appears in Collections: College of Medicine > Department of Medicine > Journal Articles

Show full item record

qrcode

Related Researcher

Researcher Lee, Gyeong Won photo

Lee, Gyeong Won: 의과대학 (의학과)

Read more

Altmetrics

Total Views & Downloads

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0534

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Related Researcher

Altmetrics

Total Views & Downloads

BROWSE